Robert DeFrantz/LinkedIn
Dec 15, 2024, 11:19
Robert DeFrantz: Overcoming Access Barriers to Treatments for Rare and Complex Cancers through Collaboration and Innovation
Robert DeFrantz, Head, US Value and Access, Oncology at Sanofi Genzyme, shared a post on LinkedIn:
“This past week, Sanofi was pleased to sponsor and attend the American Society of Hematology (ASH) Annual Meeting in San Diego.
ASH is always a significant event in the year and an important opportunity to hear about the latest advances in hematology and oncology care, while exploring how all stakeholders in the healthcare ecosystem can ensure sustainable access for those in need.
Read more on my reflections from ASH and how Sanofi Value and Access is working collaboratively to overcome access barriers to treatments for rare and complex cancers.”
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 15, 2024, 11:09
Dec 15, 2024, 11:01
Dec 15, 2024, 10:59
Dec 15, 2024, 10:57
Dec 15, 2024, 10:54
Dec 15, 2024, 10:51
Dec 15, 2024, 10:46
Dec 15, 2024, 10:40